TITLE

High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India

AUTHOR(S)
D'souza, Desiree T. B.; Mistry, Nerges F.; Vira, Tina S.; Dholakia, Yatin; Hoffner, Sven; Pasvol, Geoffrey; Nicol, Mark; Wilkinson, Robert J.
PUB. DATE
January 2009
SOURCE
BMC Public Health;2009, Vol. 9 Issue 1, p211
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: India, China and Russia account for more than 62% of multidrug resistant tuberculosis (MDRTB) globally. Within India, locations like urban metropolitan Mumbai with its burgeoning population and high incidence of TB are suspected to be a focus for MDRTB. However apart from sporadic surveys at watched sites in the country, there has been no systematic attempt by the Revised National Tuberculosis Control Programme (RNTCP) of India to determine the extent of MDRTB in Mumbai that could feed into national estimates. Drug susceptibility testing (DST) is not routinely performed as a part of programme policy and public health laboratory infrastructure, is limited and poorly equipped to cope with large scale testing. Methods: From April 2004 to January 2007 we determined the extent of drug resistance in 724 {493 newly diagnosed, previously untreated and 231 first line treatment failures (sputum-smear positive at the fifth month after commencement of therapy)} cases of pulmonary tuberculosis drawn from the RNTCP in four suboptimally performing municipal wards of Mumbai. The observations were obtained using a modified radiorespirometric Buddemeyer assay and validated by the Swedish Institute for Infectious Disease Control, Stockholm, a supranational reference laboratory. Data was analyzed utilizing SPSS 10.0 and Epi Info 2002. Results: This study undertaken for the first time in RNTCP outpatients in Mumbai reveals a high proportion of MDRTB strains in both previously untreated (24%) and treatment-failure cases (41%). Amongst new cases, resistance to 3 or 4 drug combinations (amplified drug resistance) including isoniazid (H) and rifampicin (R), was greater (20%) than resistance to H and R alone (4%) at any point in time during the study. The trend for monoresistance was similar in both groups remaining highest to H and lowest to R. External quality control revealed good agreement for H and R resistance (k = 0.77 and 0.76 respectively). Conclusion: Levels of MDRTB are much higher in both previously untreated and first line treatment-failure cases in the selected wards in Mumbai than those projected by national estimates. The finding of amplified drug resistance suggests the presence of a well entrenched MDRTB scenario. This study suggests that a wider set of surveillance sites are needed to obtain a more realistic view of the true MDRTB rates throughout the country. This would assist in the planning of an adequate response to the diagnosis and care of MDRTB.
ACCESSION #
43569851

 

Related Articles

  • Drug-resistant TB a continuing global public health threat.  // Nation's Health;May/Jun2010, Vol. 40 Issue 4, p13 

    The article focuses on the threat to global public health from multidrug-resistant tuberculosis (TB), a disease caused by bacteria that are resistant to at least the two most effective anti-TB drugs.

  • Control of Tuberculosis -- The Law and the Public's Health. Annas, George J. // New England Journal of Medicine;2/25/93, Vol. 328 Issue 8, p585 

    In this article, the author explores the legal aspects of public health efforts to contain the resurgence of tuberculosis in the U.S. According to the author, an effective public health strategy depends in large part on properly identifying the cause of the epidemic, but causes of the current...

  • South African TB patients fled hospital to spend Christmas with families.  // Infectious Disease News;Feb2008, Vol. 21 Issue 2, p43 

    This article reports on the escape of several Jose Pearson Hospital patients with both multidrug-resistant and extensively drug-resistant forms of tuberculosis to spend the Christmas holiday with their families. The incident in the Port Elizabeth, South Africa-based hospital illustrates the...

  • Drug-resistant TB in North Korea:. Cross, Catherine // CMAJ: Canadian Medical Association Journal;9/17/2013, Vol. 185 Issue 13, pE627 

    The article focuses on a paper published in "PLoS Medicine" on July 30, 2013 which describes the rising multidrug-resistant tuberculosis rates in North Korea.

  • Divergent Trends in Abortion and Birth Control Practices in Belarus, Russia and Ukraine. Denisov, Boris P.; Sakevich, Victoria I.; Jasilioniene, Aiva // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Context: The last decade witnessed growing differences in abortion dynamics in Belarus, Russia, and Ukraine despite demographic, social, and historical similarities of these nations. This paper investigates changes in birth control practices in the three countries and searches for an explanation...

  • Validation of the GenoType® MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand. Anek-vorapong, Rapeepun; Sinthuwattanawibool, Chalinthorn; Podewils, Laura Jean; McCarthy, Kimberly; Ngamlert, Keerataya; Promsarin, Busakorn; Varma, Jay K. // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p123 

    Background: Over the past several years, new diagnostic techniques have been developed to allow for the rapid detection of multidrug resistant tuberculosis. The GenoType® MTBDRplus test is a deoxyribonucleic acid (DNA) strip assay which uses polymerase chain reaction (PCR) and hybridization...

  • Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India. Atre, Sachin R; Murray, Megan B // Journal of Public Health Policy;Aug2016, Vol. 37 Issue 3, p277 

    Multidrug-resistant tuberculosis (MDR-TB) challenges TB control efforts because of delays in diagnosis plus its long-term treatment which has toxic effects. Of TB high-incidence countries, India carries the highest burden of MDR-TB cases. We describe policy issues in India concerning MDR-TB...

  • MDR TB Transmission, Singapore. Chee, Cynthia B. E.; Li-Yang Hsu; Li-Hwei Sng; Yee-Sin Leo; Cutter, Jeffery; Yee-Tang Wang // Emerging Infectious Diseases;Jul2013, Vol. 19 Issue 7, p1151 

    A letter to the editor is presented in response to the article on multidrug-resistant tuberculosis (MDR TB) transmission in Singapore.

  • India Reports New Drug-resistant TB Strain. Mason, Margie // India -- West;1/20/2012, Vol. 37 Issue 9, pA35 

    The article reports that Indian doctors discover cases of totally drug-resistant tuberculosis (TB) which are considered the first in the country.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics